Rna replicon for improving gene expression and use thereof
US-2024417751-A1 · Dec 19, 2024 · US
US2016122748A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016122748-A1 |
| Application number | US-201514928928-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 30, 2015 |
| Priority date | Oct 30, 2014 |
| Publication date | May 5, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A novel method for preparing sequence-verified oligonucleotides is disclosed. In particular, the invention relates to a simple, affordable, and scalable method that combines high-throughput mating of yeast clones, a unique selectable system for combining DNA sequences in yeast, and next-generation sequencing. This method allows sequence-verified oligonucleotides to be readily isolated from complex libraries.
Opening claim text (preview).
What is claimed is: 1 . A method for isolating a sequence-verified oligonucleotide from a composition comprising a mixture of oligonucleotides, the method comprising: a) providing the composition comprising the mixture of oligonucleotides, wherein each oligonucleotide comprises an unknown sequence and common priming sites for amplification; b) amplifying one or more oligonucleotides; c) transforming a plurality of host cells with the amplified oligonucleotides; d) plating the plurality of transformed host cells in an ordered array on media suitable for growth of the host cells; e) culturing the plurality of transformed host cells under conditions whereby each host cell produces a colony of clones in the ordered array; f) introducing an oligonucleotide from a colony in the ordered array into a barcoder cell, wherein the barcoder cell comprises a nucleic acid comprising a recombination target site for a site-specific recombinase and a barcode sequence that identifies the colony in the ordered array to which the oligonucleotide corresponds; g) translocating the oligonucleotide to a position adjacent to the barcode sequence of the barcoder cell using a site-specific recombinase system, wherein site-specific recombination with the recombination target site of the barcoder cell generates a nucleic acid comprising a barcode-oligonucleotide fusion sequence; h) sequencing the barcode-oligonucleotide fusion sequence to identify a colony in the ordered array comprising a sequence-verified oligonucleotide; i) picking a clone comprising the sequence-verified oligonucleotide from the colony in the ordered array identified by the barcode; and j) isolating the sequence-verified oligonucleotide from the clone. 2 . The method of claim 1 , wherein the oligonucleotides are amplified with a primer comprising an integration targeting sequence that is sufficiently homologous to a genomic target locus of the host cell, such that amplicons of the oligonucleotides integrate into the genome at the target locus in the transformed host cell by homologous recombination. 3 . The method of claim 2 , further comprising using a selectable marker that selects for clones that have undergone successful integration of an oligonucleotide at the genomic target locus. 4 . The method of claim 2 , further comprising transforming the plurality of host cells with a recombinant polynucleotide encoding a restriction enzyme operably linked to a promotor, wherein the restriction enzyme creates a double strand break at the genomic target locus that facilitates integration of an oligonucleotide at the genomic target locus. 5 . The method of claim 2 , wherein the genomic target locus is adjacent to a recombination target site capable of undergoing recombination with the recombination target site of the barcoder cell to produce a barcode-oligonucleotide fusion sequence. 6 . The method of claim 1 , wherein the oligonucleotides are amplified with a primer comprising a targeting sequence that is sufficiently homologous to a target locus on a plasmid in the host cell, such that the oligonucleotide amplicons integrate into the plasmid at the target locus in the transformed host cell. 7 . The method of claim 6 , further comprising using a selectable marker that selects for clones that have undergone successful integration of an oligonucleotide at the plasmid target locus. 8 . The method of claim 6 , further comprising transforming the plurality of host cells with a recombinant polynucleotide encoding a restriction enzyme operably linked to a promotor, wherein the restriction enzyme creates a double strand break at the target locus of the plasmid that facilitates integration of the oligonucleotide into the plasmid at the target locus. 9 . The method of claim 6 , wherein the plasmid target locus is adjacent to a recombination target site capable of undergoing recombination with the recombination target site of the barcoder cell to produce a barcode-oligonucleotide fusion sequence. 10 . The method of claim 1 , wherein the oligonucleotides are amplified with a primer comprising a recombination target site capable of undergoing recombination with the recombination target site of the barcoder cell. 11 . The method of claim 1 , wherein the unknown sequence of each oligonucleotide is flanked by a common 5′ restriction site and a common 3′ restriction site. 12 . The method of claim 11 , further comprising performing a restriction digest that selectively cleaves each oligonucleotide at the common 5′ restriction site and the common 3′ restriction site to produce a restriction fragment. 13 . The method of claim 12 , further comprising cloning the restriction fragment into a vector. 14 . The method of claim 13 , wherein the vector is a plasmid or viral vector. 15 . The method of claim 14 , wherein the vector further comprises a recombination target site capable of undergoing recombination with the recombination target site of the barcoder cell to produce a barcode-oligonucleotide fusion sequence. 16 . The method of claim 1 , wherein transforming the plurality of host cells comprises introducing vectors comprising the oligonucleotides into the host cells. 17 . The method of claim 1 , wherein the host cells are prokaryotic cells or eukaryotic cells. 18 . The method of claim 17 , wherein the host cells are yeast. 19 . The method of claim 17 , wherein the host cells are bacteria. 20 . The method of claim 1 , wherein the site-specific recombinase system is a Cre-loxP site-specific recombinase system, a Flp-FRT site-specific recombinase system, a PhiC31-att site-specific recombinase system, or a Dre-rox site-specific recombinase system. 21 . The method of claim 1 , further comprising using a selectable marker that selects for clones that have undergone successful site-specific recombination. 22 . The method of claim 1 , wherein amplifying the oligonucleotides is performed using a method selected from the group consisting of polymerase chain reaction (PCR), nucleic acid sequence-based amplification (NASBA), transcription mediated amplification (TMA), strand displacement amplification (SDA), and ligase chain reaction (LCR). 23 . The method of claim 22 , wherein the oligonucleotides are amplified using PCR. 24 . The method of claim 1 , wherein said plating the plurality of transformed host cells in an ordered array is performed with an automated robotic device or manually. 25 . The method of claim 1 , wherein said picking a clone is performed with an automated robotic device or manually. 26 . The method of claim 1 , further comprising amplifying the sequence-verified oligonucleotide. 27 . The method of claim 1 , further comprising removing contaminating oligonucleotides that have incorrect sequences. 28 . The method of claim 1 , wherein a set of universal primers capable of hybridizing to the common priming sites are used to amplify all the oligonucleotides in parallel. 29 . The method of claim 1 , wherein a set of selective primers are used to selectively amplify a subset of the oligonucleotides. 30 . The method of claim 1 , wherein the mixture of oligonucleotides comprises a probe library or a primer library. 31 . The method of claim 30 , further comprising using the sequence-verified oligonucleotide as a primer
mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR · CPC title
Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display · CPC title
Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms · CPC title
Isolating an individual clone by screening libraries · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.